Psychedelic clinical research firm Reunion Neuroscience Inc. (NASDAQ: REUN) is taking Mindset Pharma Inc. (OTCQB: MSSTF) to federal court over claims...
All Motions Adopted Amidst Significant Market Interest in PharmAla as a Leading GMP Manufacturer and Researcher of MDMA and Analog moleculesTORONTO, March...
The article Compass Pathways’ New Psilocybin For Depression Trial, Explained was originally published on Microdose. On February 17th, psychedelic medicine...
PharmaAla to supply the MDMA. The post Revive, PharmaTher To Partner on MDMA Patch appeared first on Green Market Report.
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle PatchVANCOUVER, British Columbia, Feb. 06, 2023...
The article News You Might Have Missed: Jan 23rd, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article Mindset Granted Patent for Lead Drug (But Reunion Also Has Patent) was originally published on Microdose. Mindset Pharma has been granted...
Investing in psychedelic companies has become increasingly popular in the past few years. Here at Psychedelic Invest, our goal is to connect you to the...
You may know Psychedelic Invest for our trackable index of public companies. You may know us for our constant stream of informative content surrounding...
Some analysts have called the industry's business model problematic. The post Despite Psychedelic Industry Buzz, Some Have Crashed Already appeared first...